Jinling Pharmaceutical Co Ltd (000919) — Net Asset Quality Index

Latest as of September 2025: 80.5%

Jinling Pharmaceutical Co Ltd (000919) has a Net Asset Quality Index of 80.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥6.02 Billion minus total liabilities of CN¥1.18 Billion yields net assets of CN¥4.85 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Jinling Pharmaceutical Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Quality Index

80.5%
Equity / Total Assets

Net Assets

CN¥4.85 Billion
CNY

Total Assets

CN¥6.02 Billion
CNY

Total Liabilities

CN¥1.18 Billion
CNY

Jinling Pharmaceutical Co Ltd Net Asset Quality Index Over Time (1996–2024)

This chart shows how Jinling Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 29 annual periods from 1996 to 2024. As of September 2025, the index stands at 80.5%, representing net assets of CN¥4.85 Billion against total assets of CN¥6.02 Billion CNY. For live market cap and overall valuation, see 000919 stock market capitalisation.

Annual Net Asset Quality Index for Jinling Pharmaceutical Co Ltd (1996–2024)

The table below presents the year-by-year Net Asset Quality Index for Jinling Pharmaceutical Co Ltd from 1996 to 2024, covering 29 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 000919 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2024 79.6% CN¥4.85 Billion CN¥6.09 Billion CN¥1.24 Billion ▼ -1.3 pp
2023 81.0% CN¥3.68 Billion CN¥4.55 Billion CN¥865.58 Million ▲ +1.1 pp
2022 79.8% CN¥3.63 Billion CN¥4.54 Billion CN¥916.30 Million ▲ +0.4 pp
2021 79.5% CN¥3.53 Billion CN¥4.45 Billion CN¥913.10 Million ▼ -0.7 pp
2020 80.1% CN¥3.43 Billion CN¥4.28 Billion CN¥850.43 Million ▼ -2.2 pp
2019 82.4% CN¥3.42 Billion CN¥4.16 Billion CN¥733.62 Million ▼ -1.2 pp
2018 83.6% CN¥3.25 Billion CN¥3.88 Billion CN¥638.90 Million ▲ +4.4 pp
2017 79.2% CN¥3.05 Billion CN¥3.86 Billion CN¥803.11 Million ▲ +0.0 pp
2016 79.1% CN¥3.05 Billion CN¥3.86 Billion CN¥804.90 Million ▲ +3.2 pp
2015 76.0% CN¥2.92 Billion CN¥3.85 Billion CN¥925.73 Million ▲ +0.0 pp
2014 75.9% CN¥2.75 Billion CN¥3.62 Billion CN¥871.24 Million ▼ -2.0 pp
2013 77.9% CN¥2.57 Billion CN¥3.30 Billion CN¥729.94 Million ▲ +0.8 pp
2012 77.1% CN¥2.47 Billion CN¥3.20 Billion CN¥733.12 Million ▼ -1.5 pp
2011 78.6% CN¥2.33 Billion CN¥2.96 Billion CN¥633.01 Million ▼ -1.6 pp
2010 80.2% CN¥2.20 Billion CN¥2.74 Billion CN¥544.47 Million ▼ -3.5 pp
2009 83.7% CN¥2.05 Billion CN¥2.46 Billion CN¥400.59 Million ▼ -1.6 pp
2008 85.3% CN¥1.88 Billion CN¥2.20 Billion CN¥324.25 Million ▲ +2.9 pp
2007 82.4% CN¥1.95 Billion CN¥2.37 Billion CN¥416.86 Million ▼ -1.3 pp
2006 83.7% CN¥1.70 Billion CN¥2.03 Billion CN¥330.39 Million ▼ -1.1 pp
2005 84.8% CN¥1.56 Billion CN¥1.84 Billion CN¥280.42 Million ▲ +2.8 pp
2004 82.0% CN¥1.47 Billion CN¥1.79 Billion CN¥322.83 Million ▼ -2.4 pp
2003 84.3% CN¥1.38 Billion CN¥1.64 Billion CN¥256.06 Million ▲ +3.6 pp
2002 80.7% CN¥1.24 Billion CN¥1.54 Billion CN¥296.79 Million ▲ +2.3 pp
2001 78.4% CN¥1.11 Billion CN¥1.42 Billion CN¥306.54 Million ▼ -8.4 pp
2000 86.8% CN¥1.06 Billion CN¥1.22 Billion CN¥161.37 Million ▼ -0.1 pp
1999 86.9% CN¥1.02 Billion CN¥1.17 Billion CN¥153.24 Million ▲ +14.6 pp
1998 72.3% CN¥312.85 Million CN¥432.49 Million CN¥119.63 Million ▼ -1.5 pp
1997 73.8% CN¥225.93 Million CN¥306.16 Million CN¥80.23 Million ▲ +5.0 pp
1996 68.8% CN¥170.16 Million CN¥247.41 Million CN¥77.25 Million
pp = percentage points